Results 51 to 60 of about 2,191 (109)
ABSTRACT Cutaneous leishmaniasis (CL) remains a therapeutic challenge in endemic regions, with 600,000–1 million new cases annually facing limited treatment options. We present a case series evaluating an innovative topical combination therapy for acute‐phase CL in Shiraz, Iran.
Hoda Haghshenas +3 more
wiley +1 more source
Current treatment of cutaneous leishmaniasis includes pentavalent antimonials as first-line drugs, but this therapy has shown severe adverse effects. An alternative to minimize this issue is based on combination therapy scheme with other drugs.
Luiz Filipe Gonçalves-Oliveira, Ph.D. +11 more
doaj +1 more source
Efficacy and Safety of Topical Dapsone in Dermatology: A Scoping Review of Clinical Studies
ABSTRACT Background Dapsone (4,4′‐Diamino diphenyl sulfone) has been utilized in managing a wide variety of mucocutaneous conditions, usually as a systemic product. Topical dapsone is commercially available as 5% and 7.5% gel and is FDA‐approved for acne vulgaris.
Bahareh Abtahi‐Naeini +4 more
wiley +1 more source
ABSTRACT This study describes the green synthesis, characterization, and biological evaluation of silver nanoparticles (AgNPs) obtained from green propolis (AgNPs‐PRO). Before nanoparticles synthesis, a hydroethanolic green propolis extract (GPE) was obtained through ultrasound‐assisted extraction and characterized by high‐performance liquid ...
Erica Tirzah S. Lima +13 more
wiley +1 more source
Background Visceral leishmaniosis is a potentially life-threatening illness caused by a protozoan parasite of the genus Leishmania. It is found mainly in areas where both the parasite and its vector are endemic and is one of the most challenging ...
Laura Manna +5 more
doaj +1 more source
Pentavalent antimonials are still the first drug of choice for the treatment of cutaneous leishmaniasis (CL). Like other treatments, they can cause adverse reactions including musculoskeletal pain, gastrointestinal disturbances, and mild to moderate ...
Omid MOZAFARI +2 more
doaj
We analyzed data from historical controls treated with meglumine antimoniate to compare the frequency of adverse events observed in patients with cutaneous leishmaniasis treated with the same dose of meglumine antimoniate contaminated with heavy metals ...
Gustavo Adolfo Sierra Romero +3 more
doaj +1 more source
Leukogram and neutrophil oxidative metabolism fromdogs with visceral leishmaniasis (VL) were compared before andafter treatment with meglumine antimoniate (AM) and with anassociation of meglumine antimoniate and allopurinol (AMA).The results obtained ...
Paulo César Ciarlini +4 more
doaj
Interventions for American cutaneous and mucocutaneous leishmaniasis: a systematic review update.
IntroductionLeishmaniasis is an important public health problem in the Americas. A Cochrane review published in 2009 analyzed 38 randomized controlled trials (RCT). We conducted a systematic review to evaluate the effects of therapeutic interventions for
Ludovic Reveiz +4 more
doaj +1 more source
Case summary A 12-year-old male neutered domestic shorthair cat underwent rhinoscopy due to inspiratory dyspnoea and stertor. Rhinoscopy showed signs of chronic rhinitis and a multinodular nasopharyngeal mucosa.
Rodolfo Oliveira Leal +5 more
doaj +1 more source

